2018
DOI: 10.1021/acssensors.8b01011
|View full text |Cite
|
Sign up to set email alerts
|

A Sample-to-Targeted Gene Analysis Biochip for Nanofluidic Manipulation of Solid-Phase Circulating Tumor Nucleic Acid Amplification in Liquid Biopsies

Abstract: The use of circulating tumor nucleic acids (ctNA) in patient liquid biopsies for targeted genetic analysis is rapidly increasing in clinical oncology. Still, the call for an integrated methodology, which is both rapid and sensitive for analyzing trace ctNA amount in liquid biopsies, has unfortunately not been fully realized. Herein, we performed complex liquid biopsy sample-to-targeted genetic analysis on a biochip with a 50 copies-detection limit within 30 min. Our biochip uniquely integrated the following: (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
38
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 50 publications
(39 citation statements)
references
References 24 publications
1
38
0
Order By: Relevance
“…In contrast, microfluidics devices have been adopted to measure cancer‐related biomarkers due to their remarkable features in bioanalysis. For genetic analysis of prostate cancer from patients' body fluids, an integrated “sample‐to‐targeted gene analysis” biochip was developed to simultaneously detect multiple prostate cancer‐specific genes ( TMPRSS2–ERG gene fusion, PCA3 , SChLAP1 , and KLK2 ) obtained from urine and serum liquid biopsies . The biochip consists of different functional domains of 1) lysing cells electrically for 60 s to release targeted genes, 2) conducting enhanced solid‐phase isothermal amplification via nanofluidic manipulation, 3) peroxidase‐mimicking nanozyme labeling, and 4) electrochemical target detection.…”
Section: Application Of Microfluidics‐based Analysismentioning
confidence: 99%
“…In contrast, microfluidics devices have been adopted to measure cancer‐related biomarkers due to their remarkable features in bioanalysis. For genetic analysis of prostate cancer from patients' body fluids, an integrated “sample‐to‐targeted gene analysis” biochip was developed to simultaneously detect multiple prostate cancer‐specific genes ( TMPRSS2–ERG gene fusion, PCA3 , SChLAP1 , and KLK2 ) obtained from urine and serum liquid biopsies . The biochip consists of different functional domains of 1) lysing cells electrically for 60 s to release targeted genes, 2) conducting enhanced solid‐phase isothermal amplification via nanofluidic manipulation, 3) peroxidase‐mimicking nanozyme labeling, and 4) electrochemical target detection.…”
Section: Application Of Microfluidics‐based Analysismentioning
confidence: 99%
“…Reproduced with permission. [137] Copyright 2018, American Chemical Society. b) Electrochemical clamp assay with Pd nanostructured microelectrodes for the detection of ctNA.…”
Section: Intramolecular Speciesmentioning
confidence: 99%
“…Regarding the analysis of NAs present in CTCs, an analytical platform integrating electrical lysis and release of cellular targets, isothermal NA amplification and nanozyme-mediated electrochemical detection has been proposed by Trau's group (Koo et al, 2018).…”
Section: Dna-based Red Diagnosticsmentioning
confidence: 99%